Loading clinical trials...
Loading clinical trials...
Screening of Prediabetes in End Stage Renal Disease on Dialysis
Prediabetes is a highly prevalent condition, affecting about one-third of adults in the United States Patients with prediabetes have an increased risk for diabetes, with 2% to 10% progressing to diabetes each yea Although prediabetes is frequently considered an intermediary stage in the progression between normoglycemia and diabetes, many individuals may have prediabetes for several years, while some may never progress.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Faculty of Medicine
Sohag, Egypt, Egypt
Sohag University .Faculty of Medicine
Sohag, Egypt
Start Date
April 13, 2025
Primary Completion Date
September 13, 2025
Completion Date
October 12, 2025
Last Updated
January 13, 2026
262
ACTUAL participants
Lead Sponsor
Sohag University
NCT06626022
NCT05608694
NCT07227480
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions